Browse > Article

Pharmacokinetic and Pharmacodynamic Characterization of Gliclazide in Healthy Volunteers  

Kim, Ho-Soon (College of Pharmacy, Chungnam National University)
Yun, Min-Hyuk (College of Pharmacy, Chungnam National University)
Kwon, Kwang-Il (College of Pharmacy, Chungnam National University)
Publication Information
Archives of Pharmacal Research / v.26, no.7, 2003 , pp. 564-568 More about this Journal
Abstract
Pharmacokinetic and pharmacodynamic properties of gliclazide were studied after an oral administration of gliclazide tablets in healthy volunteers. After an overnight fasting, gliclazide tablet was orally administered to 11 volunteers; Additional 10 volunteers were used as a control group (i.e., no gliclazide administration). Blood samples were collected, and the concentration determined for gliclazide and glucose up to 24 after the administration. Standard pharmacokinetic analysis was carried out for gliclazide. Pharmacodynamic activity of the drug was expressed by increase of glucose concentration ($\Delta$PG), by area under the increase of glucose concentration-time curve ($AUC_{$\Delta$PG}$) or by the difference in increase of glucose concentration ($D_{$\Delta$PG}$) at each time between groups with and without gliclazide administration. Pharmacokinetic analysis revealed that $C_{max}, T_{max}$, CL/F (apparent clearance), V/F (apparent volume of distribution) and half-life of gliclazide were $4.69\pm1.38 mg/L, 3.45\pm1.11 h, 1.26\pm0.35 L/h, 17.78\pm5.27 L, and 9.99\pm2.15 h$, respectively. When compared with the no drug administration group, gliclazide decreased significantly the $AUC_{$\Delta$PG}$ s at 1, 1.5, 2, 2.5, 3 and 4 h (p<0.05). The $\Delta$PGs were positively correlated with $AUC_{gliclazide}$ at 1 and 1.5 h (p<0.05), and the correlation coefficient was maximum at 1 h (r = 0.642) and gradually decreased at 4 h after the administration. The $AUC_{$\Delta$PG}$s were positively correlated with $AUC_{gliclazide}$ at 1, 2, 3 and 4 h (p<0.05), and the maximum correlation coefficient was obtained at 2 h (r=0.642) after the administration. The $D_{$\Delta$PG}$ reached the maximum at 1 h, remained constant from 1 h to 3 h, and decreased afterwards. Therefore, these observations indicated that maximum hypoglycemic effect of gliclazide was reached at approximately at 1.5 h after the administration and the effect decreased, probably because of the homeostasis mechanism, in health volunteers.
Keywords
Gliclazide; Pharmacokinetics; Pharmacodynamics; Human;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 4
연도 인용수 순위
1 Kimura, M., Kobayashi, K., Hata, M., Matsuoka, A., Kitamura, H., and Kimura, Y., Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin. J. Chromatogra., 183, 467-473 (1980)   DOI   ScienceOn
2 Palmer, K. J. and Brogden, R. N., Gliclazide. An update of its pharmacological properties and therapeutic efficacy in noninsulin-dependent diabetes mellitus. Drugs, 46, 92-125 (1993)   DOI   ScienceOn
3 Davis, T. M. E., Daly, F., Walsh, J. P., Ilett, K. F., Beilby, J. P., Dusci, L. J., and Barrett, P. H. R., Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br. J. Clin. Pharmacol., 49, 223-230 (2000)   DOI   ScienceOn
4 Glowka, F. K., Hermann, T. W., and Zabel, M., Bioavailablity of gliclazide from some formulation tablets. Int. J. Pharmceut., 172, 71-77 (1998)   DOI   ScienceOn
5 Campbell, D. B., Adrianessens, P., Hopkins, Y. W., Gordon, B., and Williams, J. R. B., Pharmacokinetics and metabolism of gliclazide: G review. In Gliclazide and the Treatment of Diabetes, Keen H. London (ed). Academic Press and the Royal Society of Medicine, 71-82 (1980)
6 Shiba, T., Kajinuma, H., Suzuki, K., Hagura, R., and Kawai, A., Serum gliclazide concentration in diabetic patients. Relationship between gliclazide and serum concentration. Diabetes Res. Clin. Prac., 2, 301-306 (1986)   DOI   ScienceOn
7 Kobayashi, K., Kimura, M., Sakoguchi, T., Kitani, Y., and Hata, M., Influence of blood protein on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide. J. Pharmacodyn., 4, 436-442 (1981)